| Dr David Benjamin Turner, MD | |
|
71 Allen St, Suite 403, Rutland, VT 05701-4570 | |
| (802) 772-4414 | |
| (802) 772-7973 |
| Full Name | Dr David Benjamin Turner |
|---|---|
| Gender | Male |
| Speciality | Obstetrics/gynecology |
| Experience | 29 Years |
| Location | 71 Allen St, Rutland, Vermont |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114010881 | NPI | - | NPPES |
| 1015238 | Medicaid | VT |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Q00000X | Family Medicine | 042-0011579 (Vermont) | Primary |
| 207V00000X | Obstetrics & Gynecology | RT-1357 (New Hampshire) | Secondary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Bayada Home Health Care | Williston, VT | Home health agency |
| Addison County Home Health & Hospice Inc | Middlebury, VT | Home health agency |
| Porter Hospital, Inc | Middlebury, VT | Hospital |
| Univ. Of Vermont - Fletcher Allen Health Care | Burlington, VT | Hospital |
| Elizabethtown Community Hospital | Elizabethtown, NY | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Five-town Health Alliance, Inc | 9638321342 | 10 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
American Industrial Systems, Inc. is an ISO 9001:2008 certified supplier and manufacturer of 15" to 20" industrial LCD monitor with stainless steel front bezels and touch screens, designed for use in the food, beverage, pharmaceutical and tobacco industries for operator control and monitoring.
Over-the-counter weight-loss pills are no quick fix to melt away extra pounds.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1336193838 PECOS PAC ID: 2961467386 Enrollment ID: O20041129000357 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
American Industrial Systems, Inc. is an ISO 9001:2008 certified supplier and manufacturer of 15" to 20" industrial LCD monitor with stainless steel front bezels and touch screens, designed for use in the food, beverage, pharmaceutical and tobacco industries for operator control and monitoring.
Over-the-counter weight-loss pills are no quick fix to melt away extra pounds.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1073567590 PECOS PAC ID: 2961467386 Enrollment ID: O20041129000784 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
American Industrial Systems, Inc. is an ISO 9001:2008 certified supplier and manufacturer of 15" to 20" industrial LCD monitor with stainless steel front bezels and touch screens, designed for use in the food, beverage, pharmaceutical and tobacco industries for operator control and monitoring.
Over-the-counter weight-loss pills are no quick fix to melt away extra pounds.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1104870922 PECOS PAC ID: 2961467386 Enrollment ID: O20050131001023 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
American Industrial Systems, Inc. is an ISO 9001:2008 certified supplier and manufacturer of 15" to 20" industrial LCD monitor with stainless steel front bezels and touch screens, designed for use in the food, beverage, pharmaceutical and tobacco industries for operator control and monitoring.
Over-the-counter weight-loss pills are no quick fix to melt away extra pounds.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
| Entity Name | Porter Hospital Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1053331389 PECOS PAC ID: 1850365180 Enrollment ID: O20050919000670 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
American Industrial Systems, Inc. is an ISO 9001:2008 certified supplier and manufacturer of 15" to 20" industrial LCD monitor with stainless steel front bezels and touch screens, designed for use in the food, beverage, pharmaceutical and tobacco industries for operator control and monitoring.
Over-the-counter weight-loss pills are no quick fix to melt away extra pounds.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1467681114 PECOS PAC ID: 2961467386 Enrollment ID: O20100804000784 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
American Industrial Systems, Inc. is an ISO 9001:2008 certified supplier and manufacturer of 15" to 20" industrial LCD monitor with stainless steel front bezels and touch screens, designed for use in the food, beverage, pharmaceutical and tobacco industries for operator control and monitoring.
Over-the-counter weight-loss pills are no quick fix to melt away extra pounds.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
| Entity Name | Community Health Centers Of The Rutland Region Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1780969345 PECOS PAC ID: 2961467386 Enrollment ID: O20120321000420 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
American Industrial Systems, Inc. is an ISO 9001:2008 certified supplier and manufacturer of 15" to 20" industrial LCD monitor with stainless steel front bezels and touch screens, designed for use in the food, beverage, pharmaceutical and tobacco industries for operator control and monitoring.
Over-the-counter weight-loss pills are no quick fix to melt away extra pounds.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
| Entity Name | Five-town Health Alliance, Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1871840843 PECOS PAC ID: 9638321342 Enrollment ID: O20121204000030 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
American Industrial Systems, Inc. is an ISO 9001:2008 certified supplier and manufacturer of 15" to 20" industrial LCD monitor with stainless steel front bezels and touch screens, designed for use in the food, beverage, pharmaceutical and tobacco industries for operator control and monitoring.
Over-the-counter weight-loss pills are no quick fix to melt away extra pounds.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Dr David Benjamin Turner, MD 2987 Route 22a, Shoreham, VT 05770-9728 Ph: (802) 897-7000 | Dr David Benjamin Turner, MD 71 Allen St, Suite 403, Rutland, VT 05701-4570 Ph: (802) 772-4414 |
News Archive
Roche announced today that new 5 year follow-up data from two pivotal studies with Herceptin(R) (trastuzumab) in early breast cancer; key results from a study of Avastin(R) (bevacizumab) in the second-line treatment of advanced breast cancer and strong data on the use of trastuzumab-DM1 (T-DM1), the first antibody-drug conjugate in development for very advanced HER2-positive breast cancer, will all be presented during the CTRC-AACR San Antonio Breast Cancer Symposium (SABCS) from 9 to 13 December 2009.
American Industrial Systems, Inc. is an ISO 9001:2008 certified supplier and manufacturer of 15" to 20" industrial LCD monitor with stainless steel front bezels and touch screens, designed for use in the food, beverage, pharmaceutical and tobacco industries for operator control and monitoring.
Over-the-counter weight-loss pills are no quick fix to melt away extra pounds.
Among patients with persistently high cholesterol despite high-intensity statin therapy, the proprotein convertase subtilisin-kexin 9 (PCSK9) inhibitor alirocumab reduced rates of major adverse cardiovascular events by 15 percent compared with placebo, in a study presented at the American College of Cardiology's 67th Annual Scientific Session.
› Verified 9 days ago
Richard Carleton Baker, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 215 Stratton Rd, Rutland, VT 05701 Phone: 802-773-3386 Fax: 802-773-4578 | |
Lisa Hogenkamp, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 10 Commons St, Rutland, VT 05701 Phone: 802-747-3359 Fax: 802-786-5204 | |
Frederick Hesse, Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 199 Stratton Rd Ste 1, Rutland, VT 05701 Phone: 802-775-7798 Fax: 802-775-7762 | |
Susan E Blish, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 Fax: 802-747-6260 | |
Dr. Bruce D Bullock, MD Family Medicine Medicare: Accepting Medicare Assignments Practice Location: 8 Commons St, Rutland, VT 05701 Phone: 802-770-1805 Fax: 802-773-4876 | |
Dr. Megan Dawn Wright, MD Family Medicine Medicare: Medicare Enrolled Practice Location: 160 Allen St, Rutland, VT 05701 Phone: 802-775-7111 |